Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Agreement between skeletal muscle mass measurements using computed tomography imaging and magnetic resonance imaging in head and neck cancer patients
Najiba Chargi, Ejaz Ansari, Laura F. J. Huiskamp, et al.
Oral Oncology (2019) Vol. 99, pp. 104341-104341
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting
Panagiota Economopoulou, Remco de Bree, Ioannis Kotsantis, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 160
Radiologically Defined Sarcopenia Affects Survival in Head and Neck Cancer: A Meta‐Analysis
Amanda Wong, Daniel Zhu, Dennis H. Kraus, et al.
The Laryngoscope (2020) Vol. 131, Iss. 2, pp. 333-341
Closed Access | Times Cited: 89
Effect of hydration schedules on dose‐limiting toxicity in patients with head and neck squamous cell carcinoma treated with cisplatin
Anouk W. M. A. Schaeffers, Cassimy B. van Neerven, D. van Balen, et al.
British Journal of Clinical Pharmacology (2025)
Open Access | Times Cited: 1
The use of alternate vertebral levels to L3 in computed tomography scans for skeletal muscle mass evaluation and sarcopenia assessment in patients with cancer: a systematic review
Belinda Vangelov, Judith Bauer, Damian P. Kotevski, et al.
British Journal Of Nutrition (2021) Vol. 127, Iss. 5, pp. 722-735
Closed Access | Times Cited: 49
Role of sarcopenia on survival and treatment-related toxicity in head and neck cancer: a narrative review of current evidence and future perspectives
Enes Erul, Deniz Can Güven, Mehmet Ruhi Onur, et al.
European Archives of Oto-Rhino-Laryngology (2023) Vol. 280, Iss. 8, pp. 3541-3556
Closed Access | Times Cited: 21
Skeletal muscle mass and sarcopenia can be determined with 1.5-T and 3-T neck MRI scans, in the event that no neck CT scan is performed
Aniek T. Zwart, Jan-Niklas Becker, Maria J. Lamers, et al.
European Radiology (2020) Vol. 31, Iss. 6, pp. 4053-4062
Open Access | Times Cited: 44
Measurement of Sarcopenia in Head and Neck Cancer Patients and Its Association With Frailty
Remco de Bree, C Meerkerk, György B. Halmos, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 27
Sarcopenia and its impact in head and neck cancer treatment
Remco de Bree, Maartje A. van Beers, Anouk W. M. A. Schaeffers
Current Opinion in Otolaryngology & Head & Neck Surgery (2022) Vol. 30, Iss. 2, pp. 87-93
Open Access | Times Cited: 23
Skeletal muscle mass is an imaging biomarker for decreased survival in patients with oropharyngeal squamous cell carcinoma
Najiba Chargi, Sandra I. Bril, Justin E. Swartz, et al.
Oral Oncology (2019) Vol. 101, pp. 104519-104519
Open Access | Times Cited: 38
The Predictive Value of Low Skeletal Muscle Mass Assessed on Cross-Sectional Imaging for Anti-Cancer Drug Toxicity: A Systematic Review and Meta-Analysis
Laura F. J. Huiskamp, Najiba Chargi, Lot A. Devriese, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 11, pp. 3780-3780
Open Access | Times Cited: 32
Low skeletal muscle mass predicts frailty in elderly head and neck cancer patients
C Meerkerk, Najiba Chargi, Pim A. de Jong, et al.
European Archives of Oto-Rhino-Laryngology (2021) Vol. 279, Iss. 2, pp. 967-977
Open Access | Times Cited: 24
Impact of Changes in Skeletal Muscle Mass Index on Prognosis During Alternating Chemoradiotherapy in Nasopharyngeal Carcinoma
Mariko Ichinose, Kazuhira Endo, Nobuyuki Hirai, et al.
Nutrition and Cancer (2025), pp. 1-11
Closed Access
Change of skeletal muscle mass and associated factors during radiotherapy and chemoradiotherapy in patients with head and neck squamous cell carcinoma
Anouk W. M. A. Schaeffers, Hannah A. Scholten, Annemieke Kok, et al.
Oral Oncology Reports (2025), pp. 100737-100737
Open Access
Sarcopenia measured with handgrip strength and skeletal muscle mass to assess frailty in older patients with head and neck cancer
C Meerkerk, Najiba Chargi, Pim A. de Jong, et al.
Journal of Geriatric Oncology (2020) Vol. 12, Iss. 3, pp. 434-440
Open Access | Times Cited: 23
Validation of skeletal muscle mass assessment at the level of the third cervical vertebra in patients with head and neck cancer
Sandra I. Bril, Najiba Chargi, Anne W. Wendrich, et al.
Oral Oncology (2021) Vol. 123, pp. 105617-105617
Open Access | Times Cited: 19
Image-based analysis of skeletal muscle mass predicts cisplatin dose-limiting toxicity in patients with locally advanced head and neck cancer
Najiba Chargi, Fereshta Bashiri, Anne W. Wendrich, et al.
European Archives of Oto-Rhino-Laryngology (2022) Vol. 279, Iss. 7, pp. 3685-3694
Closed Access | Times Cited: 13
The predictive and prognostic value of low skeletal muscle mass for dose-limiting toxicity and survival in head and neck cancer patients receiving concomitant cetuximab and radiotherapy
Laura F. J. Huiskamp, Najiba Chargi, Lot A. Devriese, et al.
European Archives of Oto-Rhino-Laryngology (2020) Vol. 277, Iss. 10, pp. 2847-2858
Open Access | Times Cited: 19
Association of low skeletal muscle mass and systemic inflammation with surgical complications and survival after microvascular flap reconstruction in patients with head and neck cancer
Najiba Chargi, Omar Breik, Tymour Forouzanfar, et al.
Head & Neck (2022) Vol. 44, Iss. 10, pp. 2077-2094
Open Access | Times Cited: 10
Prognostic significance of MRI-defined sarcopenia in patients with nasopharyngeal carcinoma: A propensity score matched analysis of real-world data
Shuyi Liu, Yujian Zou, Minying Zhong, et al.
Radiotherapy and Oncology (2023) Vol. 188, pp. 109904-109904
Closed Access | Times Cited: 6
Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol
Anouk W. M. A. Schaeffers, Lot A. Devriese, Carla H. van Gils, et al.
PLoS ONE (2023) Vol. 18, Iss. 11, pp. e0294147-e0294147
Open Access | Times Cited: 6
Patterns, Predictors, and Prognostic Value of Skeletal Muscle Mass Loss in Patients with Locally Advanced Head and Neck Cancer Undergoing Cisplatin-Based Chemoradiotherapy
Najiba Chargi, Inge Wegner, Navid Markazi, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 8, pp. 1762-1762
Open Access | Times Cited: 13
Cut-off values for low skeletal muscle mass at the level of the third cervical vertebra (C3) in patients with head and neck cancer
Najiba Chargi, Sandra I. Bril, Ernst J. Smid, et al.
Quantitative Imaging in Medicine and Surgery (2022) Vol. 12, Iss. 6, pp. 3024-3033
Open Access | Times Cited: 9
The association between skeletal muscle mass and sensorineural hearing loss upon cisplatin‐based chemoradiotherapy in patients with head and neck squamous cell carcinoma
Anouk W. M. A. Schaeffers, Anouk V. M. Burger, Charlotte W. Duinkerken, et al.
Head & Neck (2024)
Open Access | Times Cited: 1
The effect of skeletal muscle mass on dose-limiting toxicities during (chemo)radiotherapy in patients with head and neck cancer: A systematic review and meta-analysis
Anouk W. M. A. Schaeffers, Hannah A. Scholten, Maartje A. van Beers, et al.
Oral Oncology (2024) Vol. 157, pp. 106978-106978
Open Access | Times Cited: 1
Association of preoperative low skeletal muscle mass with postoperative complications after selective neck dissection
Ejaz Ansari, Najiba Chargi, Robert J.J. van Es, et al.
International Journal of Oral and Maxillofacial Surgery (2022) Vol. 51, Iss. 11, pp. 1389-1393
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top